Literature DB >> 30858304

σB Inhibits Poly-N-Acetylglucosamine Exopolysaccharide Synthesis and Biofilm Formation in Staphylococcus aureus.

Jaione Valle1, Maite Echeverz1, Iñigo Lasa2.   

Abstract

Staphylococcus aureus clinical strains are able to produce at least two distinct types of biofilm matrixes: biofilm matrixes made of the polysaccharide intercellular adhesin (PIA) or poly-N-acetylglucosamine (PNAG), whose synthesis is mediated by the icaADBC locus, and biofilm matrixes built of proteins (polysaccharide independent). σB is a conserved alternative sigma factor that regulates the expression of more than 100 genes in response to changes in environmental conditions. While numerous studies agree that σB is required for polysaccharide-independent biofilms, controversy persists over the role of σB in the regulation of PIA/PNAG-dependent biofilm development. Here, we show that genetically unrelated S. aureus σB-deficient strains produced stronger biofilms under both static and flow conditions and accumulated higher levels of PIA/PNAG exopolysaccharide than their corresponding wild-type strains. The increased accumulation of PIA/PNAG in the σB mutants correlated with a greater accumulation of the IcaC protein showed that it was not due to adjustments in icaADBC operon transcription and/or icaADBC mRNA stability. Overall, our results reveal that in the presence of active σB, the turnover of Ica proteins is accelerated, reducing the synthesis of PIA/PNAG exopolysaccharide and consequently the PIA/PNAG-dependent biofilm formation capacity.IMPORTANCE Due to its multifaceted lifestyle, Staphylococcus aureus needs a complex regulatory network to connect environmental signals with cellular physiology. One particular transcription factor, named σB (SigB), is involved in the general stress response and the expression of virulence factors. For many years, great confusion has existed about the role of σB in the regulation of the biofilm lifestyle in S. aureus Our study demonstrated that σB is not necessary for exopolysaccharide-dependent biofilms and, even more, that S. aureus produces stronger biofilms in the absence of σB The increased accumulation of exopolysaccharide correlates with higher stability of the proteins responsible for its synthesis. The present findings reveal an additional regulatory layer to control biofilm exopolysaccharide synthesis under stress conditions.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Biofilm; PNAG; SigB; Staphylococcus aureuszzm321990; ica operon

Mesh:

Substances:

Year:  2019        PMID: 30858304      PMCID: PMC6509662          DOI: 10.1128/JB.00098-19

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  60 in total

1.  Natural conjugative plasmids induce bacterial biofilm development.

Authors:  J M Ghigo
Journal:  Nature       Date:  2001-07-26       Impact factor: 49.962

2.  The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation.

Authors:  S E Cramton; C Gerke; N F Schnell; W W Nichols; F Götz
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Bap, a Staphylococcus aureus surface protein involved in biofilm formation.

Authors:  C Cucarella; C Solano; J Valle; B Amorena; I Lasa ; J R Penadés
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

4.  Sigma(B) activity depends on RsbU in Staphylococcus aureus.

Authors:  P Giachino; S Engelmann; M Bischoff
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

5.  Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.

Authors:  D McKenney; K L Pouliot; Y Wang; V Murthy; M Ulrich; G Döring; J C Lee; D A Goldmann; G B Pier
Journal:  Science       Date:  1999-05-28       Impact factor: 47.728

Review 6.  Staphylococcus and biofilms.

Authors:  Friedrich Götz
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

7.  Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate.

Authors:  S Rachid; K Ohlsen; U Wallner; J Hacker; M Hecker; W Ziebuhr
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

8.  In vivo effects of sporulation kinases on mutant Spo0A proteins in Bacillus subtilis.

Authors:  J D Quisel; W F Burkholder; A D Grossman
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

9.  Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation.

Authors:  B T Bateman; N P Donegan; T M Jarry; M Palma; A L Cheung
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

10.  Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide.

Authors:  Tomás Maira-Litrán; Andrea Kropec; C Abeygunawardana; Joseph Joyce; George Mark; Donald A Goldmann; Gerald B Pier
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  9 in total

1.  Biofilm properties in relation to treatment outcome in patients with first-time periprosthetic hip or knee joint infection.

Authors:  Karin Svensson Malchau; Jonatan Tillander; Magdalena Zaborowska; Maria Hoffman; Iñigo Lasa; Peter Thomsen; Henrik Malchau; Ola Rolfson; Margarita Trobos
Journal:  J Orthop Translat       Date:  2021-08-19       Impact factor: 5.191

Review 2.  Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.

Authors:  Katrin Schilcher; Alexander R Horswill
Journal:  Microbiol Mol Biol Rev       Date:  2020-08-12       Impact factor: 11.056

3.  Within-host evolution of bovine Staphylococcus aureus selects for a SigB-deficient pathotype characterized by reduced virulence but enhanced proteolytic activity and biofilm formation.

Authors:  Helene Marbach; Katharina Mayer; Claus Vogl; Jean Y H Lee; Ian R Monk; Daniel O Sordelli; Fernanda R Buzzola; Monika Ehling-Schulz; Tom Grunert
Journal:  Sci Rep       Date:  2019-09-17       Impact factor: 4.379

4.  One evolutionarily selected amino acid variation is sufficient to provide functional specificity in the cold shock protein paralogs of Staphylococcus aureus.

Authors:  Arancha Catalan-Moreno; Carlos J Caballero; Naiara Irurzun; Sergio Cuesta; Jacinto López-Sagaseta; Alejandro Toledo-Arana
Journal:  Mol Microbiol       Date:  2020-01-12       Impact factor: 3.501

5.  Extracellular DNA, cell surface proteins and c-di-GMP promote biofilm formation in Clostridioides difficile.

Authors:  Lisa F Dawson; Johann Peltier; Catherine L Hall; Mark A Harrison; Maria Derakhshan; Helen A Shaw; Neil F Fairweather; Brendan W Wren
Journal:  Sci Rep       Date:  2021-02-05       Impact factor: 4.379

6.  Molecular docking and simulation of IcaC protein as O-succinyltransferase function in staphylococcus epidermidis biofilm formation.

Authors:  Ramachandira Prabu; Amaresh Mohanty; Susmida Seni Balakrishnan; G Jayalakshmi; Kothandapani Sundar
Journal:  Curr Res Struct Biol       Date:  2022-03-26

7.  Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.

Authors:  Margarita Trobos; Rininta Firdaus; Karin Svensson Malchau; Jonatan Tillander; Dimitrios Arnellos; Ola Rolfson; Peter Thomsen; Iñigo Lasa
Journal:  Microbiol Spectr       Date:  2022-06-28

8.  Treatment of periprosthetic joint infections guided by minimum biofilm eradication concentration (MBEC) in addition to minimum inhibitory concentration (MIC): protocol for a prospective randomised clinical trial.

Authors:  Jonatan A N Tillander; Karin Rilby; Karin Svensson Malchau; Susann Skovbjerg; Erika Lindberg; Ola Rolfson; Margarita Trobos
Journal:  BMJ Open       Date:  2022-09-15       Impact factor: 3.006

Review 9.  Strategies to prevent, curb and eliminate biofilm formation based on the characteristics of various periods in one biofilm life cycle.

Authors:  Ruixiang Ma; Xianli Hu; Xianzuo Zhang; Wenzhi Wang; Jiaxuan Sun; Zheng Su; Chen Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-09-21       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.